(Q43623886)

25 November 2017

title

Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy: a preliminary study (English)

1 reference

25 November 2017

0 references

Komoroski RA

1

1 reference

25 November 2017

Pearce JM

2

1 reference

25 November 2017

Griffin WS

3

1 reference

25 November 2017

Mrak RE

4

1 reference

25 November 2017

Omori M

5

1 reference

25 November 2017

Karson CN

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

106

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

171-180

1 reference

Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Increased concentrations of phosphatidylinositol (PI) and decreased esterification of arachidonic acid into phospholipids in platelets from patients with schizoaffective disorders or atypic phasic psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

The platelet polyphosphoinositide system in schizophrenia: the effects of neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Haloperidol improves membrane phospholipid abnormalities in temporal lobes of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

The membrane hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

31P-NMR study of brain phospholipid structures in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Red cell phospholipids in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Increased platelet membrane lysophosphatidylcholine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Resolution of phospholipid molecular species by 31P NMR

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Analysis of phospholipid molecular species in brain by (31)P NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Increased turnover of platelet phosphatidylinositol in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900081-6

7 January 2021

10.1016/S0925-4927(01)00081-6

Identifiers

DOI

1 reference

25 November 2017

1 reference